vs
Side-by-side financial comparison of NELNET INC (NNI) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $33.5M, roughly 1.7× NELNET INC). NELNET INC runs the higher net margin — 172.3% vs -83.0%, a 255.2% gap on every dollar of revenue. On growth, NELNET INC posted the faster year-over-year revenue change (79.6% vs 36.9%). Over the past eight quarters, NELNET INC's revenue compounded faster (62.0% CAGR vs 48.5%).
Nelnet, Inc. is a United States–based conglomerate that primarily focuses on financial services including student and consumer loan origination and servicing. Additionally, the company operates an investing arm, an internet bank and has a 26% stake in Allo Fiber, a cable and internet provider. The company is headquartered in Lincoln, Nebraska.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
NNI vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $33.5M | $57.3M |
| Net Profit | $57.8M | $-47.5M |
| Gross Margin | 50.5% | 91.6% |
| Operating Margin | — | -82.2% |
| Net Margin | 172.3% | -83.0% |
| Revenue YoY | 79.6% | 36.9% |
| Net Profit YoY | -8.5% | -9.6% |
| EPS (diluted) | $1.62 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $33.5M | $57.3M | ||
| Q3 25 | $23.2M | $51.3M | ||
| Q2 25 | $26.1M | $48.5M | ||
| Q1 25 | $24.7M | $32.7M | ||
| Q4 24 | $18.7M | $41.8M | ||
| Q3 24 | $16.6M | $33.3M | ||
| Q2 24 | $14.9M | $29.1M | ||
| Q1 24 | $12.8M | $26.0M |
| Q4 25 | $57.8M | $-47.5M | ||
| Q3 25 | $106.7M | $-52.9M | ||
| Q2 25 | $181.5M | $-46.6M | ||
| Q1 25 | $82.6M | $-49.5M | ||
| Q4 24 | $63.2M | $-43.3M | ||
| Q3 24 | $2.4M | $-43.6M | ||
| Q2 24 | $45.1M | $-32.3M | ||
| Q1 24 | $73.4M | $-141.4M |
| Q4 25 | 50.5% | 91.6% | ||
| Q3 25 | 29.6% | 89.3% | ||
| Q2 25 | 29.8% | 88.6% | ||
| Q1 25 | 30.5% | 88.8% | ||
| Q4 24 | 13.7% | 90.9% | ||
| Q3 24 | 0.1% | 88.5% | ||
| Q2 24 | 27.3% | 89.9% | ||
| Q1 24 | 15.3% | 89.2% |
| Q4 25 | — | -82.2% | ||
| Q3 25 | — | -102.6% | ||
| Q2 25 | — | -93.4% | ||
| Q1 25 | — | -143.7% | ||
| Q4 24 | 97.7% | -98.6% | ||
| Q3 24 | -13.4% | -132.0% | ||
| Q2 24 | 88.0% | -139.2% | ||
| Q1 24 | — | -538.7% |
| Q4 25 | 172.3% | -83.0% | ||
| Q3 25 | 460.5% | -103.1% | ||
| Q2 25 | 694.9% | -96.1% | ||
| Q1 25 | 334.4% | -151.4% | ||
| Q4 24 | 338.2% | -103.6% | ||
| Q3 24 | 14.4% | -131.2% | ||
| Q2 24 | 303.6% | -110.9% | ||
| Q1 24 | 574.4% | -544.4% |
| Q4 25 | $1.62 | $-0.73 | ||
| Q3 25 | $2.94 | $-0.82 | ||
| Q2 25 | $4.97 | $-0.75 | ||
| Q1 25 | $2.26 | $-0.81 | ||
| Q4 24 | $1.74 | $-0.71 | ||
| Q3 24 | $0.07 | $-0.73 | ||
| Q2 24 | $1.23 | $-0.55 | ||
| Q1 24 | $1.98 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $296.0M | $388.9M |
| Total DebtLower is stronger | $7.8B | — |
| Stockholders' EquityBook value | $3.7B | $139.1M |
| Total Assets | $14.1B | $480.2M |
| Debt / EquityLower = less leverage | 2.11× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $296.0M | $388.9M | ||
| Q3 25 | $216.4M | $416.1M | ||
| Q2 25 | $225.8M | $291.0M | ||
| Q1 25 | $220.5M | $314.5M | ||
| Q4 24 | $194.5M | $320.6M | ||
| Q3 24 | $219.7M | $298.4M | ||
| Q2 24 | $145.5M | $319.1M | ||
| Q1 24 | $179.7M | $201.2M |
| Q4 25 | $7.8B | — | ||
| Q3 25 | $7.8B | — | ||
| Q2 25 | $7.9B | — | ||
| Q1 25 | $8.7B | — | ||
| Q4 24 | $8.3B | — | ||
| Q3 24 | $8.9B | — | ||
| Q2 24 | $9.6B | — | ||
| Q1 24 | $10.6B | — |
| Q4 25 | $3.7B | $139.1M | ||
| Q3 25 | $3.7B | $148.8M | ||
| Q2 25 | $3.6B | $-11.9M | ||
| Q1 25 | $3.4B | $18.9M | ||
| Q4 24 | $3.3B | $21.7M | ||
| Q3 24 | $3.3B | $11.2M | ||
| Q2 24 | $3.3B | $39.3M | ||
| Q1 24 | $3.3B | $61.6M |
| Q4 25 | $14.1B | $480.2M | ||
| Q3 25 | $13.9B | $506.9M | ||
| Q2 25 | $13.7B | $372.7M | ||
| Q1 25 | $14.2B | $386.7M | ||
| Q4 24 | $13.8B | $392.3M | ||
| Q3 24 | $14.1B | $363.6M | ||
| Q2 24 | $14.5B | $381.8M | ||
| Q1 24 | $15.4B | $258.7M |
| Q4 25 | 2.11× | — | ||
| Q3 25 | 2.14× | — | ||
| Q2 25 | 2.21× | — | ||
| Q1 25 | 2.53× | — | ||
| Q4 24 | 2.48× | — | ||
| Q3 24 | 2.72× | — | ||
| Q2 24 | 2.90× | — | ||
| Q1 24 | 3.20× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $423.0M | $-25.4M |
| Free Cash FlowOCF − Capex | $396.7M | — |
| FCF MarginFCF / Revenue | 1183.0% | — |
| Capex IntensityCapex / Revenue | 78.2% | — |
| Cash ConversionOCF / Net Profit | 7.32× | — |
| TTM Free Cash FlowTrailing 4 quarters | $663.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $423.0M | $-25.4M | ||
| Q3 25 | $112.4M | $-26.6M | ||
| Q2 25 | $81.8M | $-23.3M | ||
| Q1 25 | $91.2M | $-40.4M | ||
| Q4 24 | $662.9M | $-18.8M | ||
| Q3 24 | $137.0M | $-25.2M | ||
| Q2 24 | $133.8M | $-29.1M | ||
| Q1 24 | $211.6M | $-40.7M |
| Q4 25 | $396.7M | — | ||
| Q3 25 | $100.8M | — | ||
| Q2 25 | $78.1M | — | ||
| Q1 25 | $87.8M | — | ||
| Q4 24 | $642.0M | — | ||
| Q3 24 | $132.6M | — | ||
| Q2 24 | $123.1M | — | ||
| Q1 24 | $188.3M | — |
| Q4 25 | 1183.0% | — | ||
| Q3 25 | 435.0% | — | ||
| Q2 25 | 299.0% | — | ||
| Q1 25 | 355.6% | — | ||
| Q4 24 | 3438.0% | — | ||
| Q3 24 | 797.9% | — | ||
| Q2 24 | 829.2% | — | ||
| Q1 24 | 1473.7% | — |
| Q4 25 | 78.2% | — | ||
| Q3 25 | 50.4% | — | ||
| Q2 25 | 14.2% | — | ||
| Q1 25 | 13.7% | — | ||
| Q4 24 | 111.9% | — | ||
| Q3 24 | 26.7% | — | ||
| Q2 24 | 71.5% | — | ||
| Q1 24 | 181.7% | — |
| Q4 25 | 7.32× | — | ||
| Q3 25 | 1.05× | — | ||
| Q2 25 | 0.45× | — | ||
| Q1 25 | 1.10× | — | ||
| Q4 24 | 10.50× | — | ||
| Q3 24 | 57.39× | — | ||
| Q2 24 | 2.97× | — | ||
| Q1 24 | 2.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
